Giovannelli e Associati advised Altheia Science, a biotech start-up incorporated to develop curative medicine for autoimmune diseases (multiple sclerosis and diabetes) on the capital increase of its corporate capital.
The team of Giovannelli e Associati comprised partner Gianvittorio Giroletti Angeli and associate Matilde Finucci.
Read More: